Vimta Labs Limited (NSE:VIMTALABS)

Market Cap	22.13B +17.1%
Revenue (ttm)	3.94B +11.6%
Net Income	741.31M +20.8%
EPS	16.49 +20.8%
Shares Out	n/a
PE Ratio	29.86
Forward PE	n/a
Dividend	1.00 (0.20%)
Ex-Dividend Date	May 30, 2025

Volume	210,036
Average Volume	400,703
Open	498.20
Previous Close	495.90
Day's Range	482.75 - 499.60
52-Week Range	400.30 - 902.65
Beta	-0.57
RSI	49.10
Earnings Date	Jan 28, 2026

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 1,315
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIMTALABS

Financial Performance

In fiscal year 2025, Vimta Labs's revenue was 3.45 billion, an increase of 19.25% compared to the previous year's 2.90 billion. Earnings were 667.55 million, an increase of 36.76%.